Referred Tests
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing. | |
Test ID: MSMRT
Mayo Algorithmic Approach for Stratification of Myeloma and Risk-Adapted Therapy Report, Bone Marrow
Useful For 
Suggests clinical disorders or settings where the test may be helpful
Risk stratification of patients with multiple myeloma, which can assist in determining treatment and management decisions
Risk stratification of patients with newly diagnosed multiple myeloma
Reflex Tests Lists tests that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial tests.
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| MPCPD | mSMART Eval, PCPD, FISH | No | No |
Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.
Based on the flow cytometric analysis and presence of greater than or equal to 0.1% monotypic plasma cells, the MPCPD / mSMART, Plasma Cell Proliferative Disorder (PCPD), FISH test will be reflexed and performed at an additional charge.
See Laboratory Screening Tests for Suspected Multiple Myeloma in Special Instructions.
Special Instructions Library of PDFs including pertinent information and forms related to the test
Method Name A short description of the method used to perform the test
Flow Cytometry/DNA Content/Cell Cycle Analysis
NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Reporting Name Lists a shorter or abbreviated version of the Published Name for a test
mSMART Algorithmic Testing, BM
Aliases Lists additional common names for a test, as an aid in searching
Labeling Index
Myeloma Staging
PC Proliferation
PCLIP
Plasma Cell Labeling Index (PCLI)
Plasma Cell Staging
+1q or CKS1B
+3/+7
+9/+15
-13 (monosomy 13)
13q- / -13 (13q deletion) or RB1
17p- (17p deletion) or TP53
IGH (14q32) rearrangement
Monoclonal Gammopathy of Unknown Significance (MGUS)
Multiple Myeloma
MYC (8q24.1) rearrangement
Plasma Cell Leukemia
t(11;14)-CCND1/IGH
t(14;16)-IGH/MAF
t(14;20)-IGH/MAFB
t(4;14)-FGFR3/IGH
t(6;14)-CCND3/IGH
Myeloma Staging
PC Proliferation
PCLIP
Plasma Cell Labeling Index (PCLI)
Plasma Cell Staging
+1q or CKS1B
+3/+7
+9/+15
-13 (monosomy 13)
13q- / -13 (13q deletion) or RB1
17p- (17p deletion) or TP53
IGH (14q32) rearrangement
Monoclonal Gammopathy of Unknown Significance (MGUS)
Multiple Myeloma
MYC (8q24.1) rearrangement
Plasma Cell Leukemia
t(11;14)-CCND1/IGH
t(14;16)-IGH/MAF
t(14;20)-IGH/MAFB
t(4;14)-FGFR3/IGH
t(6;14)-CCND3/IGH